High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity data

M Ghilezan, A Martinez, G Gustason, D Krauss… - International Journal of …, 2012 - Elsevier
PURPOSE: To report the toxicity profile of high-dose-rate (HDR)-brachytherapy (BT) as
monotherapy in a Human Investigation Committee-approved study consisting of a single …
被引用次数：103 相关文章

High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity …

M Ghilezan, A Martinez, G Gustason… - International Journal of …, 2012 - redjournal.org
Purpose To report the toxicity profile of high-dose-rate (HDR)-brachytherapy (BT) as
monotherapy in a Human Investigation Committee-approved study consisting of a single …

High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity …

M Ghilezan, A Martinez, G Gustason, D Krauss… - International Journal of …, 2012 - osti.gov
Purpose: To report the toxicity profile of high-dose-rate (HDR)-brachytherapy (BT) as
monotherapy in a Human Investigation Committee-approved study consisting of a single …

[引用][C] High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary …

M Ghilezan, A Martinez, G Gustason, D Krauss… - International Journal of …, 2012 - cir.nii.ac.jp
High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for
Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity Data | CiNii Research CiNii …

High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity …

M Ghilezan, A Martinez, G Gustason… - International Journal of …, 2012 - inis.iaea.org
[en] Purpose: To report the toxicity profile of high-dose-rate (HDR)-brachytherapy (BT) as
monotherapy in a Human Investigation Committee-approved study consisting of a single …

High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity data.

M Ghilezan, A Martinez, G Gustason… - … Journal of Radiation …, 2011 - europepmc.org
Purpose To report the toxicity profile of high-dose-rate (HDR)-brachytherapy (BT) as
monotherapy in a Human Investigation Committee-approved study consisting of a single …

High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity data

M Ghilezan, A Martinez, G Gustason… - … journal of radiation …, 2012 - pubmed.ncbi.nlm.nih.gov
Purpose To report the toxicity profile of high-dose-rate (HDR)-brachytherapy (BT) as
monotherapy in a Human Investigation Committee-approved study consisting of a single …

High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity …

M Ghilezan, A Martinez, G Gustason, D Krauss… - International Journal of …, 2012 - infona.pl
To report the toxicity profile of high-dose-rate (HDR)-brachytherapy (BT) as monotherapy in
a Human Investigation Committee-approved study consisting of a single implant and two …

[引用][C] High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary …

M GHILEZAN, A MARTINEZ… - … journal of radiation …, 2012 - pascal-francis.inist.fr
High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day
for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity Data CNRS Inist …

[引用][C] High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable

M GHILEZAN, A MARTINEZ, G GUSTASON… - International journal of …, 2012 - Elsevier